Pharm-Rx Lidocaine Hydrochloride
- CAS Number
- 73-78-9
- Chemical Name
- Lidocaine Hydrochloride
- Molecular Formula
- C₁₄H₂₂N₂O · HCl · H₂O
Pharm-Rx Lidocaine Hydrochloride, comprising lidocaine hydrochloride, functions in over-the-counter (OTC) capacities within pharmaceuticals and nutraceuticals. Categorized as an active pharmaceutical ingredient (API) under pharmaceutical actives and precursors in pharmaceuticals and nutraceutical technologies, it serves as a crucial component in various formulations due to its anesthetic properties.
Properties
- Physical Form
- Powder
- Pharma and Nutraceuticals Functions
- OTC
Product families
Applications
- Other Drug & Care Solutions
Product Families
- Active Pharmaceutical Ingredients (APIs)
Other characteristics
- Chemical Inventories
- AICS (Australia), NZIoC (New Zealand)
- AICS (Australia)
- NZIoC (New Zealand)
- Certifications & Compliance
- California Proposition 65, FDA 29 CFR 1910.1200
- Markets
- Healthcare & Pharma
- Definition
Lidocaine Hydrochloride contains not less than 97.5% and not more than 102.5% of lidocaine hydrochloride (C₁₄H₂₂N₂O · HCl), calculated on the anhydrous basis.
- Soluble In
- Chloroform Soluble
- Ethanol Soluble
- Water Soluble
- Technology
- Pharmaceuticals & Nutraceuticals
- FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- Storage Information
Preserve in well-closed containers. Store at controlled room temperature.
- Labelling Information
Where it is intended for use in preparing injectable dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
- USP Reference Standards
USP Lidocaine Hydrochloride RS USP Lidocaine Related Compound H RS 2-Chloro-N-(2,6-dimethylphenyl)acetamide; C10H12ClNO 197.66 USP Ropivacaine Related Compound A RS 2,6-Dimethylaniline hydrochloride; C8H11N · HCl 157.64
- Certifications and Compliance
- California Proposition 65
- FDA 29 CFR 1910.1200
Technical data
Table 1 of 1
1 row| Characteristic | Value |
|---|---|
| Molecular Weight | 288.81 |
